SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is attracting significant community attention and discussion, particularly as its proponents rally around the upcoming 4/20 event, promoting its mission to advance global cannabis culture and legalization on the Solana blockchain as a crypto 'like Bitcoin but way higher'.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU CRYPTO is trending due to its highly active community's relentless focus on building a "permissionless brand," highlighted by the continuous launch of real-world products like "Kendu Spice" and "Kendu Unleashed" skateboards. The community remains overwhelmingly bullish, emphasizing the project's strong fundamentals and long-term vision amidst prevailing market conditions.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares (LABU) is experiencing a strong rally, propelled by increasing market conviction in AI's transformative role in drug discovery, significant M&A activity, and growing expectations for rate cuts that are driving a sector-wide breakout.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X Shares

Direxion Daily S&P Biotech Bear 3X Shares

LABD is trending amidst community frustration and significant losses as the biotech sector (XBI) maintains an unexpected bull run, driven by ongoing M&A and perceived market manipulation, defying numerous bearish technical indicators.

GhostwareOS (GHOST) is the Full-Stack Privacy Layer of Solana — a next-generation AI-driven infrastructure for encrypted communication, anonymous identity management, and untraceable transactions. By combining advanced zero-knowledge protocols with autonomous AI routing, GhostwareOS allows users and developers to operate invisibly across Web3. It powers decentralized apps that demand true digital anonymity, scalable privacy, and zero metadata leakage — restoring control to users in an overexposed internet age.

Ghost

GHOST is capturing attention as the "privacy layer of Solana," bolstered by integrations with Solflare and partnerships like Zebec, with its low market cap sparking community excitement for substantial growth and utility in the current market.

WorldFinancial

WLFI is trending as it faces a U.S. House investigation into a significant $500 million investment deal, sparking a polarized community debate. While many critics denounce it as a politically-linked "scam," proponents are aggressively buying dips, anticipating future growth from its planned app and real-world asset tokenization initiatives.

ProShares Trust - ProShares Ultra VIX Short-Term Futures ETF 1.5x Shares

ProShares Ultra VIX Short-Term Futures ETF

ProShares Ultra VIX Short-Term Futures ETF (UVXY) is trending due to ongoing geopolitical tensions and market uncertainty, with investors actively debating its potential for significant volatility spikes as a hedge against downturns, while others focus on shorting rallies given its inherent decay.

Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment consists of end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through the company's two core offerings, Canopy and Horizon. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

Ginkgo Bioworks is trending as its collaboration with OpenAI on an AI-driven autonomous lab, achieving significant cost reductions in protein synthesis, sparks community debate on its potential as critical national biotechnology infrastructure amid broader sector tailwinds for AI and biodefense.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

SCHD is trending as investors seek a flight to safety, with the dividend-focused ETF holding strong and showing green performance during broader market downturns. The community is actively discussing a potential rotation from high-growth tech into value and income strategies, reinforcing SCHD's appeal as a long-term, defensive holding.

McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs. The RxTS segment offers prescription price transparency, benefit insight, dispensing support services, third-party logistics, and wholesale distribution. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The International segment refers to the distribution and services to wholesale, institutional, and retail customers in Europe and Canada. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.

Mckesson Corporation

McKesson (MCK) is trending after reporting strong earnings that beat estimates and raising its fiscal year guidance, igniting bullish sentiment across the community. Investors are highlighting its consistent performance as a healthcare sector "juggernaut," driven by robust growth in specialty distribution and oncology, leading to multiple analyst price target upgrades.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ventas Q4 Earnings Call Highlights

Ventas (NYSE:VTR) executives told investors the company delivered what CEO Deborah A. Cafaro described as an outstanding year in 2025, driven primarily by senior housing momentum under the company's...

S&P Poised for Biggest Advance Since May  The Close 2/6/2026

Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after the closing bell on Wall Street. Today's guests are Principal Asset...

Ventas (NYSE:VTR) Hits New 12-Month High Following Dividend Announcement

Ventas (NYSE:VTR) Sets New 12-Month High After Dividend Announcement...

Ventas Q4 FFO Meet, Revenues Beat Estimates, Same-Store Cash NOI Rises

VTR posts strong Q4 FFO results with higher FFO and revenues, fueled by gains in SHOP and OM&R offsetting a dip in triple-net results.

Ventas, Inc. (NYSE:VTR) Increases Dividend to $0.52 Per Share

Ventas, Inc. (NYSE:VTR) declared a quarterly dividend on Thursday, February 5th. Shareholders of record on Tuesday, March 31st will be paid a dividend of 0.52 per share by the real estate investment...

Jones Financial Companies Lllp Has $6.09 Million Stock Holdings in Ventas, Inc. $VTR

Jones Financial Companies Lllp grew its stake in Ventas, Inc. (NYSE:VTR - Free Report) by 21.6% during the third quarter, according to the company in its most recent filing with the Securities...

Ventas, Inc. (NYSE:VTR) Given Average Recommendation of "Moderate Buy" by Analysts

Shares of Ventas, Inc. (NYSE:VTR - Get Free Report) have earned an average recommendation of "Moderate Buy" from the seventeen research firms that are presently covering the firm, Marketbeat reports...

Ventas (NYSE:VTR) Issues FY 2026 Earnings Guidance

Ventas (NYSE:VTR) updated its FY 2026 earnings guidance. The company provided EPS guidance of 3.780-3.880 for the period, compared to the consensus estimate of 1.840...

Ventas (VTR) Reports Q4 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Ventas (VTR) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Ventas (NYSE:VTR) Announces Earnings Results, Misses Estimates By $0.74 EPS

Ventas (NYSE:VTR - Get Free Report) issued its quarterly earnings data on Thursday. The real estate investment trust reported $0.15 earnings per share for the quarter, missing analysts' consensus...

$VTR Q4 &#39;25 Earnings Results &amp; Recap

• Reported GAAP EPS of $0.15 up 15.38% YoY
• Reported revenue of $1.55B up 21.62% YoY
• Ventas expects full year 2026 Normalized FFO per share guidance of $3.78 to $3.88, representing 6% to 9% year-over-year growth, and projects Attributable Net Income per share between $0.52 and $0.62.

Stocktwits

Ventas Inc

 Q4 '25 Earnings Results & Recap

• Reported GAAP EPS of $0.15 up 15.38% YoY
• Reported revenue of $1.55B up 21.62% YoY
• Ventas expects full year 2026 Normalized FFO per share guidance of $3.78 to $3.88, representing 6% to 9% year-over-year growth, and projects Attributable Net Income per share between $0.52 and $0.62.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Ventas, Inc. engages in the acquisition and ownership of seniors housing and healthcare properties. It operates through the following segments: Senior Housing Operating Portfolio (SHOP), Outpatient Medical and Research Portfolio (OM&R), and Triple-net Leased Properties (NNN). The SHOP segment is involved in owning and investing in senior housing communities throughout the United States and Canada. The OM&R segment refers to acquiring, owning, development, leasing and managing outpatient medical buildings and research centers throughout the United States. The NNN segment focuses on investing and owning senior housing communities, skilled nursing facilities, long-term acute care facilities, freestanding inpatient rehabilitation facilities, and other healthcare facilities throughout the United States and the United Kingdom. The company was founded in 1983 and is headquartered in Chicago, IL.

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

What will be the S&amp;P 500’s next 5% move?

What will be the S&P 500’s next 5% move?

VTR
Ventas Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest VTR News

VTRVentas Inc